These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


288 related items for PubMed ID: 6495894

  • 1. [Hemorheologic changes in ankylosing spondylitis].
    Ernst E, Roloff C, Magyarosy J, Drexel H.
    Z Rheumatol; 1984; 43(4):190-2. PubMed ID: 6495894
    [Abstract] [Full Text] [Related]

  • 2. [Hemorheologic and clinical changes in ankylosing spondylitis during hyperthermia].
    Matrai A, Ernst E.
    Acta Med Austriaca; 1991; 18(5):120-4. PubMed ID: 1796724
    [Abstract] [Full Text] [Related]

  • 3. [Hemorheologic changes in chronic polyarthritis].
    Schöps P, Seichert N, Thies W, Erdl R, Schattenkirchner M, Ernst E.
    Z Rheumatol; 1988; 47(1):52-7. PubMed ID: 2453101
    [Abstract] [Full Text] [Related]

  • 4. Comparison of piroxicam with indomethacin in ankylosing spondylitis: a double-blind crossover trial.
    Sydnes OA.
    Br J Clin Pract; 1981 Jan; 35(1):40-4. PubMed ID: 7020732
    [No Abstract] [Full Text] [Related]

  • 5. [Hemorheologic parameters in patients with giant cell arteritis before and after treatment with steroids].
    Wiek J, Krause M, Wiederholt M, Hansen LL.
    Fortschr Ophthalmol; 1990 Jan; 87(6):671-4. PubMed ID: 2086417
    [Abstract] [Full Text] [Related]

  • 6. Using serial haemorheological parameters to assess clinical status in sickle cell anaemia patients in vaso-occlussive crisis.
    Awodu OA, Famodu AA, Ajayi OI, Enosolease ME, Olufemi OY, Olayemi E.
    Clin Hemorheol Microcirc; 2009 Jan; 41(2):143-8. PubMed ID: 19252237
    [Abstract] [Full Text] [Related]

  • 7. [Therapy of ankylosing spondylitis. Short-term use of piroxicam suppositories or indomethacin suppositories and retard capsules].
    Stollenwerk R, von Criegern T, Gierend M, Schilling F.
    Fortschr Med; 1985 May 23; 103(20):561-5. PubMed ID: 3874137
    [No Abstract] [Full Text] [Related]

  • 8. [Feldene (piroxicam) in the treatment of ankylosing spondylitis].
    Sadowska-Wróblewska M, Garwolińska H, Radzikowska B.
    Reumatologia; 1983 May 23; 21(1):55-8. PubMed ID: 6359311
    [No Abstract] [Full Text] [Related]

  • 9. [Piroxicam--a step forward in the treatment of rheumatism].
    Fischer M.
    Med Klin; 1980 Aug 15; 75(17):633-5. PubMed ID: 6997718
    [No Abstract] [Full Text] [Related]

  • 10. [Decreased blood fluidity in progressive systemic scleroderma].
    Ernst E, Lohmaier EF, Meurer M, Gerstmeier J.
    Z Rheumatol; 1990 Aug 15; 49(3):155-9. PubMed ID: 2378174
    [Abstract] [Full Text] [Related]

  • 11. Clinical perspectives in rheumatology: a review of three common forms of arthritis and results of United States trials with isoxicam.
    Calabro JJ, Londino AV.
    Singapore Med J; 1985 Feb 15; 26(1):17-28. PubMed ID: 3895442
    [No Abstract] [Full Text] [Related]

  • 12. Effect of immunoglobulin administration on blood rheology in patients with septic shock.
    Madl C, Koppensteiner R, Wendelin B, Lenz K, Kramer L, Grimm G, Kranz A, Schneeweiss B, Ehringer H.
    Circ Shock; 1993 Aug 15; 40(4):264-7. PubMed ID: 8375028
    [Abstract] [Full Text] [Related]

  • 13. [The flow properties of blood and their characterization by hemorheologic methods].
    Lerche D, Bäumler H, Kucera W, Meier W, Paulitschke M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989 Aug 15; 116(5):631-52. PubMed ID: 2481610
    [Abstract] [Full Text] [Related]

  • 14. [Changes in flow properties of the blood in pregnancy].
    Heilmann L.
    Zentralbl Gynakol; 1986 Aug 15; 108(7):393-402. PubMed ID: 3716677
    [Abstract] [Full Text] [Related]

  • 15. [Hemorrheologic disorders in obese patients. Study of the viscosity of the blood, erythrocytes, plasma, fibrinogen and the erythrocyte filtration index].
    Craveri A, Tornaghi G, Paganardi L, Ranieri R, Leonardi G, Di Bella M.
    Minerva Med; 1987 Jul 15; 78(13):899-906. PubMed ID: 3601135
    [Abstract] [Full Text] [Related]

  • 16. [Hemorheological changes in retinal vein occlusions].
    Peduzzi M, Debbia A, Guerrieri F, Zirilli E, Bolzani R, Barbieri U.
    Ric Clin Lab; 1985 Jul 15; 15 Suppl 1():321-6. PubMed ID: 4035223
    [Abstract] [Full Text] [Related]

  • 17. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
    Szapáry L, Szóts M, Horváth B, Márton Z, Alexy T, Késmárky G, Juricskay I, Nagy F, Gaál V, Pálfi A, Koltai K, Tóth K.
    Orv Hetil; 2003 Jun 01; 144(22):1085-90. PubMed ID: 12847818
    [Abstract] [Full Text] [Related]

  • 18. [Hemorheologic studies for evaluating microcirculation in patients with peripheral arterial circulatory disorders and diabetes mellitus].
    Sternitzky R, Hänsgen K, Podhaisky H, Frank I, Klare M, Preuss EG.
    Z Gesamte Inn Med; 1986 Oct 01; 41(19):539-42. PubMed ID: 3811440
    [Abstract] [Full Text] [Related]

  • 19. [The course of hemorheologic parameters in acute cerebral ischemia].
    Lechner H, Ott E, Ossama N, Fazekas F.
    Wien Med Wochenschr; 1986 Oct 01; 136 Spec No():47-9. PubMed ID: 3825171
    [Abstract] [Full Text] [Related]

  • 20. Hemorheological alterations in patients with diabetic retinopathy.
    Vekasi J, Marton ZS, Kesmarky G, Cser A, Russai R, Horvath B.
    Clin Hemorheol Microcirc; 2001 Oct 01; 24(1):59-64. PubMed ID: 11345235
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.